Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 07/14/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
57 | |
| 07/14/20 | 8-K | Current report filing |
|
44 | |
| 07/13/20 | 8-K | Current report filing |
|
5 | |
| 07/10/20 | 8-K | Current report filing |
|
5 | |
| 07/07/20 | 8-K | Current report filing |
|
41 | |
| 06/29/20 | 8-K | Current report filing |
|
5 | |
| 06/29/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
5 | |
| 06/22/20 | 8-K | Current report filing |
|
7 | |
| 06/19/20 | 8-K | Current report filing |
|
3 | |
| 06/18/20 | 8-K | Current report filing |
|
6 |
